Last viewed: EBS


Prices are updated after-hours



nyse:EBS Emergent Biosolutions, Inc.

EBS | $45.59 | twitter stocktwits trandingview |
Health Technology

(0.0% 1d) (-0.5% 1m) (-58.6% 1y) (0.0% 2d) (-3.5% 3d) (-7.8% 7d) (-17.4% volume)
http://www.emergentbiosolutions.com
Sec Filling | Patents | 1834 employees

Emergent BioSolutions Inc. engages in the development, manufacture, and commercialization of medical countermeasures. It offers specialty products for civilian and military populations that address accidental, intentional and naturally occurring public health threats. The firm's products include ACAM2000, BioThrax, Raxibacuma, Vaxchora, and VIGIV. Its business units include Vaccines and Anti-Infectives; Antibody Therapeutics; Devices; and Contract Development and Manufacturing. The company was founded by Fuad El-Hibri in May 1998 and is headquartered in Gaithersburg, MD.

add to today's watch list email alert is off




vaccine   antibody  

Press-releases


Founder and Executive Chairman of Emergent BioSolutions Announces RetirementFuad El-Hibri to Retire After More Than 20 Years
Published: 2022-01-14 (Crawled : 12:30) - biospace.com/
EBS | $45.59 | twitter stocktwits trandingview |
Health Technology
| | O: 1.84% H: 0.0% C: 0.0%

ces air merge
Soligenix Corporate Update Letter - Key Highlights and Upcoming Catalysts
Published: 2022-01-10 (Crawled : 13:30) - biospace.com/
SNGX | $0.6461 | twitter stocktwits trandingview |
Health Technology
| | O: -2.45% H: 0.28% C: -1.92%
EBS | $45.59 | twitter stocktwits trandingview |
Health Technology
| | O: -0.23% H: 4.29% C: 4.15%


Emergent BioSolutions is to Participate in Investor Conferences
Published: 2022-01-03 (Crawled : 13:30) - biospace.com/
EBS | $45.59 | twitter stocktwits trandingview |
Health Technology
| | O: 0.74% H: 10.09% C: 9.55%

ces conference merge
Emergent BioSolutions Announces Initiation of Phase 1 Study Evaluating Its Universal Influenza Vaccine Candidate
Published: 2021-12-16 (Crawled : 13:30) - biospace.com/
EBS | $45.59 | twitter stocktwits trandingview |
Health Technology
| | O: 3.55% H: 2.32% C: 0.54%

ces phase 1 vaccine influenza merge
SiTime Set to Join S&P MidCap 400; Emergent BioSolutions to Join S&P SmallCap 600
Published: 2021-11-22 (Crawled : 23:00) - prnewswire.com
UFS | $55.49 | twitter stocktwits trandingview |
Process Industries
| | O: -0.02% H: 0.09% C: 0.04%
SPGI | $432.13 | twitter stocktwits trandingview |
Commercial Services
| | O: -1.72% H: 0.0% C: 0.0%
EBS | $45.59 | twitter stocktwits trandingview |
Health Technology
| | O: 5.89% H: 3.86% C: 0.9%

merge
Opiant Pharmaceuticals Announces Third Quarter 2021 Financial Results and Provides Corporate Update
Published: 2021-11-11 (Crawled : 23:00) - biospace.com/
OPNT | $27.07 | twitter stocktwits trandingview |
Health Technology
| | O: 0.78% H: 0.42% C: 0.42%
EBS | $45.59 | twitter stocktwits trandingview |
Health Technology
| | O: -0.31% H: 2.6% C: 1.29%

financial results results
BriaCell Appoints Renowned Pharmaceutical Veteran Jane Gross, Ph.D. to its Board of Directors
Published: 2021-11-02 (Crawled : 14:00) - globenewswire.com
BMY | $64.72 | twitter stocktwits trandingview |
Health Technology
| | O: 0.31% H: 0.0% C: 0.0%
APVO | News | $6.73 | twitter stocktwits trandingview |
Health Technology
| | O: 0.06% H: 5.09% C: -0.06%
EBS | $45.59 | twitter stocktwits trandingview |
Health Technology
| | O: 0.14% H: 1.96% C: 1.96%
LIFE | $6.69 | twitter stocktwits trandingview |
Health Technology
| | O: 0.46% H: 0.0% C: -0.23%
BCTX | $8.03 | twitter stocktwits trandingview |
Professional, Scientific, and T...
| | O: 1.99% H: 9.31% C: 7.32%
AMGN | News | $233.74 | twitter stocktwits trandingview |
Health Technology
| | O: 0.34% H: 2.0% C: 1.78%


Emergent BioSolutions to Release Third Quarter 2021 Financial Results and Conduct a Conference Call on November 4, 2021
Published: 2021-10-18 (Crawled : 11:00) - globenewswire.com
EBS | $45.59 | twitter stocktwits trandingview |
Health Technology
| | O: -3.26% H: 1.6% C: 0.52%

financial results results merge conference
Top 12 Biotech Companies Hiring Now
Published: 2021-10-06 (Crawled : 05:00) - biospace.com/
EBS | $45.59 | twitter stocktwits trandingview |
Health Technology
| | O: -1.66% H: 1.76% C: 0.88%

biotech iot
Emergent BioSolutions Secures Multi-Year Development and Manufacturing Agreement with Providence Therapeutics for its mRNA COVID-19 Vaccine Candidate, PTX-COVID19-B
Published: 2021-09-14 (Crawled : 12:15) - globenewswire.com
EBS | $45.59 | twitter stocktwits trandingview |
Health Technology
| | O: 0.03% H: 0.87% C: -0.28%

covid vaccine multi-year merge
See all


Last 15 days Sec forms
File Id Form Date Direction Code Amount Transacted Owned Amount
0001367644-21-000101 4 2021-05-27 Sell S 3139 14377


Your Today's Watch List
Sign in to create a watchlist
Today's Insiders Buying

Yesterday's Insiders Buying